Interestingly, in previous studies, we have demonstrated that MYH9 interacted with ENKUR and antagonized ENKUR to induce‐cell growth and metastasis in hepatocellular carcinoma, lung adenocarcinoma, and nasopharyngeal carcinoma via suppressing p53 or elevating c‐Myc.13, 14, 15. Here, MYH9 is linked to hepatocellular carcinoma.